Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo) adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial

Hofheinz, R. and Wenz, F. K. and Post, S. and Matzdorff, A. and Laechelt, S. and Hartmann, J. T. and Mueller, L. and Link, H. and Moehler, M. H. and Kettner, E. and Fritz, E. and Hieber, U. and Lindemann, H. W. and Grunewald, M. and Kremers, S. and Constantin, C. and Hipp, M. and Gencer, D. and Burkholder, I. and Hochhaus, A. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo) adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 3504. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Petra Gürster
Date Deposited: 30 Apr 2020 06:17
Last Modified: 30 Apr 2020 06:17
URI: https://pred.uni-regensburg.de/id/eprint/20807

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.